Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging

Neurology

Volumn 53, Issue 9, 1999, Pages 2182-2184

  Yoneda, Makoto ^a   Maeda, M ^a   Kimura, H ^a   Fujii, A ^a   Katayama, K ^b   Kuriyama, M ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

Author keywords

Apparent diffusion coefficient maps; MELAS; MRI; Stroke like episodes

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; HUMAN; IMAGE ANALYSIS; MELAS SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032763818     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.9.2182     Document Type: Article

References (10)

1. Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998;10: 530-542.
2. Askanas V, Engel WK. Does expression of βAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion-body myositis, cultured human muscle and transgenic mice. Am J Pathol 1998;153:1673-1677.
3. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis. Arch Neurol 1991;48:1229-1234.
4. Askanas V, McFerrin J, Baqué S, Alvarez RB, Sarkozi E, Engel WK. Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci USA 1996; 93:1314-1319.
5. Askanas V, McFerrin J, Alvarez RB, Baqué S, Engel WK. βAPP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport 1997;8:2155-2158.
6. McFerrin J, Engel WK, Askanas V. Impaired innervation of cultured human muscle overexpressing βAPP experimentally and genetically: relevance to inclusion-body myopathies. Neuroreport 1998;9:3201-3205.
7. Askanas V, Engel WK. Cultured normal and genetically abnormal human muscle. In: Rowland LP, DiMauro S, eds. The handbook of clinical neurology, myopathies. Vol 18. Amsterdam: Elsevier Science Publishers, 1992:85-116.
8. Selkoe DJ. Alzheimer's disease: genotypes, phenotype, and treatments. Science 1997;275:630-631.
9. Hardy J. The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc Natl Acad Sci USA 1997;94:2095-2097.
10. Engel WK, Askanas V. Treatment of inclusion-body myositis and hereditary inclusion-body myopathy with reference to pathogenic mechanisms: personal experience. In: Askanas V, Serratrice G, Engel WK, eds. Inclusion-body myositis and myopathies. Cambridge, United Kingdom: Cambridge University Press, 1998:351-382.